DL-PLA | DL100-14E

DL100-14E is an ester-terminated Pharma / Medical Grade copolymer of DL-lactide with an inherent viscosity between 1.30 – 1.70 dL/g. It is supplied in the form of white to light tan micronized powder. DL100-14E is primarily used for drug delivery applications and is suitable for all commonly used formulation techniques.

CAS Number:
26023-30-3

Manufacturing Process:
Ring-Opening

Synonyms:
Poly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Injectable Poly-Dl-lactic Acid, Ultra-Pure DL-PLA

Price (per Gram)

 320.00 / per Gram
SKU: DL10014E Categories: , Tags: , , , ,
Get Quote

Additional information

Appearance

EPA Registry Name

Polylactic acid

Systematic Name

Injectable Poly-Dl-lactic Acid, Poly(2-hydroxy propionic acid), Polylactic acid, Poly DL-lactide, Ultra-Pure PDLLA

Substance Type

Biodegradable Polymer, DL- Lactide 100%, Ester terminated, Excipient, Inherent Viscosity : 1.3 – 1.7 dL/g, Nanoparticles, Non-Active pharmaceutical ingredient, DL10014E

Applications

ACL Scrow, bioresorbable implants, Drug delivery formulations

Synonym(s)

PDLLA, Poly(DL-lactide) acid terminated, DLPLA

Solubility

,

FT NMR (PROTON)

Viscosity (0.5% in CHCl3 at 30°C)

FT IR

Residual monomer DL-Lactide

Residual solvent acetone

Residual solvent toluene

Acid number

Heavy metal

Tin

Sulphated Ash

TAMC

TYMC

Bacterial Endotoxins

Self life

End Group

Ester terminated

Molecular Weight

190,000 – 240,000 da

Get Quote for DL-PLA | DL100-14E